These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
236 related articles for article (PubMed ID: 29773063)
41. The utility of side-chain cyclization in determining the receptor-bound conformation of peptides: cyclic tripeptides and angiotensin II. Kataoka T; Beusen DD; Clark JD; Yodo M; Marshall GR Biopolymers; 1992 Nov; 32(11):1519-33. PubMed ID: 1333831 [TBL] [Abstract][Full Text] [Related]
43. Inhibition of Aurora-A/N-Myc Protein-Protein Interaction Using Peptidomimetics: Understanding the Role of Peptide Cyclization. Dawber RS; Gimenez D; Batchelor M; Miles JA; Wright MH; Bayliss R; Wilson AJ Chembiochem; 2024 Jan; 25(2):e202300649. PubMed ID: 37907395 [TBL] [Abstract][Full Text] [Related]
45. Peptidomimetic therapeutics: scientific approaches and opportunities. Qvit N; Rubin SJS; Urban TJ; Mochly-Rosen D; Gross ER Drug Discov Today; 2017 Feb; 22(2):454-462. PubMed ID: 27856346 [TBL] [Abstract][Full Text] [Related]
46. Synthesis of AApeptides. Niu Y; Hu Y; Wu H; Cai J Methods Mol Biol; 2013; 1081():35-46. PubMed ID: 24014432 [TBL] [Abstract][Full Text] [Related]
47. Chemoselective cyclization of unprotected linear peptides by α-ketoacid-hydroxylamine amide-ligation. Fukuzumi T; Ju L; Bode JW Org Biomol Chem; 2012 Aug; 10(30):5837-44. PubMed ID: 22426859 [TBL] [Abstract][Full Text] [Related]
48. Directed Evolution of a Cyclized Peptoid-Peptide Chimera against a Cell-Free Expressed Protein and Proteomic Profiling of the Interacting Proteins to Create a Protein-Protein Interaction Inhibitor. Kawakami T; Ogawa K; Hatta T; Goshima N; Natsume T ACS Chem Biol; 2016 Jun; 11(6):1569-77. PubMed ID: 27010125 [TBL] [Abstract][Full Text] [Related]
49. Efficient backbone cyclization of linear peptides by a recombinant asparaginyl endopeptidase. Harris KS; Durek T; Kaas Q; Poth AG; Gilding EK; Conlan BF; Saska I; Daly NL; van der Weerden NL; Craik DJ; Anderson MA Nat Commun; 2015 Dec; 6():10199. PubMed ID: 26680698 [TBL] [Abstract][Full Text] [Related]
50. Cyclization strategies in peptide derived drug design. Li P; Roller PP Curr Top Med Chem; 2002 Mar; 2(3):325-41. PubMed ID: 11944823 [TBL] [Abstract][Full Text] [Related]
51. Application of the Ugi reaction with multiple amino acid-derived components: synthesis and conformational evaluation of piperazine-based minimalist peptidomimetics. Stucchi M; Cairati S; Cetin-Atalay R; Christodoulou MS; Grazioso G; Pescitelli G; Silvani A; Yildirim DC; Lesma G Org Biomol Chem; 2015 May; 13(17):4993-5005. PubMed ID: 25821154 [TBL] [Abstract][Full Text] [Related]
52. Protein Epitope Mimetics: From New Antibiotics to Supramolecular Synthetic Vaccines. Zerbe K; Moehle K; Robinson JA Acc Chem Res; 2017 Jun; 50(6):1323-1331. PubMed ID: 28570824 [TBL] [Abstract][Full Text] [Related]
54. Peptides and proteins as a continuing exciting source of inspiration for peptidomimetics. Liskamp RM; Rijkers DT; Kruijtzer JA; Kemmink J Chembiochem; 2011 Jul; 12(11):1626-53. PubMed ID: 21751324 [TBL] [Abstract][Full Text] [Related]
55. β-Peptoid Foldamers at Last. Laursen JS; Engel-Andreasen J; Olsen CA Acc Chem Res; 2015 Oct; 48(10):2696-704. PubMed ID: 26176689 [TBL] [Abstract][Full Text] [Related]
56. The practice of ring constraint in peptidomimetics using bicyclic and polycyclic amino acids. Hanessian S; Auzzas L Acc Chem Res; 2008 Oct; 41(10):1241-51. PubMed ID: 18646869 [TBL] [Abstract][Full Text] [Related]
57. Conformational and topographical considerations in designing agonist peptidomimetics from peptide leads. Hruby VJ; Balse PM Curr Med Chem; 2000 Sep; 7(9):945-70. PubMed ID: 10911024 [TBL] [Abstract][Full Text] [Related]
58. Allosteric Modulator Leads Hiding in Plain Site: Developing Peptide and Peptidomimetics as GPCR Allosteric Modulators. Olson KM; Traynor JR; Alt A Front Chem; 2021; 9():671483. PubMed ID: 34692635 [TBL] [Abstract][Full Text] [Related]